Incruse Ellipta and Verapamil Extended Release Capsules
Determining the interaction of Incruse Ellipta and Verapamil Extended Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Verapamil Extended Release Tablets
- Incruse Ellipta-Verapamil Hydrochloride
- Incruse Ellipta-Verapamil Hydrochloride PM
- Incruse Ellipta-Verapamil Immediate-Release Tablets
- Incruse Ellipta-Verapamil Injection
- Incruse Ellipta-Verapamil Intravenous
- Verapamil Extended Release Capsules-Indacaterol
- Verapamil Extended Release Capsules-Indacaterol and Glycopyrrolate
- Verapamil Extended Release Capsules-Indacaterol and glycopyrrolate Inhalation
- Verapamil Extended Release Capsules-Indacaterol inhalation
- Verapamil Extended Release Capsules-Indacaterol Maleate
- Verapamil Extended Release Capsules-Indapamide